Immunohistochemical expression status of four biomarkers; hormone receptors [estrogen receptor (ER), progesterone receptor (PR)], human epidermal growth factor receptor (HER2), and Ki-67, are key determinants of breast cancer molecular subtyping [2]. This evidence concerns the gene ERBB2 and breast carcinoma.